Elanco Animal Health Incorporated
Cash Flow Statement
| Line Item | FY2017 | FY2016 |
|---|---|---|
| Operating Activities | ||
| Net Income | $-310.7M | $-47.9M |
| Depreciation & Amortization | $318.4M | $254.4M |
| Depreciation | $79.8M | $75.7M |
| Amortization | $221.2M | $170.7M |
| Stock-Based Compensation | $25.0M | $20.4M |
| Net Cash from Operating Activities | $173.8M | $155.9M |
| Investing Activities | ||
| Capital Expenditures | $98.6M | $110.3M |
| Business Acquisitions | $882.1M | $45.0M |
| Net Cash from Investing Activities | $-964.6M | $-182.1M |
| Financing Activities | ||
| Dividends Paid | — | — |
| Stock Repurchases | — | — |
| Net Cash from Financing Activities | $847.5M | $-149.6M |
| Net Change in Cash | $64.6M | $-201.8M |
| Free Cash Flow | $75.2M | $45.6M |